Clinical trial

Adderall XR and Cognitive Impairment in MS

NCT02676739

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2016-05-20

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2016-05-20Date precision: day

Registry last updated2024-10-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

Adderall XRDRUG

Sponsors & collaborators

Sarah Morrowlead sponsor

Mapped research locations

TorontoOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02676739 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.